1. Home
  2. PRHI vs HIND Comparison

PRHI vs HIND Comparison

Compare PRHI & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PRHI

Presurance Holdings Inc.

SELL

Current Price

$6.93

Market Cap

18.7M

Sector

Finance

ML Signal

SELL

Logo Vyome Holdings Inc.

HIND

Vyome Holdings Inc.

HOLD

Current Price

$2.17

Market Cap

15.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRHI
HIND
Founded
2009
2017
Country
United States
United States
Employees
N/A
2
Industry
Property-Casualty Insurers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
18.7M
15.2M
IPO Year
2015
2016

Fundamental Metrics

Financial Performance
Metric
PRHI
HIND
Price
$6.93
$2.17
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
7.2K
6.3K
Earning Date
05-13-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
64.86
EPS
1.66
N/A
Revenue
$43,304,000.00
$319,714.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.89
N/A
Revenue Growth
N/A
24.43
52 Week Low
$0.48
$1.75
52 Week High
$7.95
$9.56

Technical Indicators

Market Signals
Indicator
PRHI
HIND
Relative Strength Index (RSI) 67.98 50.96
Support Level $0.60 $1.99
Resistance Level N/A $2.35
Average True Range (ATR) 1.02 0.09
MACD 0.07 -0.01
Stochastic Oscillator 100.00 31.31

Price Performance

Historical Comparison
PRHI
HIND

About PRHI Presurance Holdings Inc.

Presurance Holdings Inc is an insurance holding company that markets and services product offerings through specialty personal insurance lines of business. Through its personal insurance lines, it offers homeowners insurance and dwelling fire insurance products to individuals in several states. The specialty homeowners insurance product line is comprised of low-value dwelling insurance tailored for owners of lower valued homes, which it offers in Texas, Illinois and Indiana. Through commercial insurance lines, it offers coverage for both commercial property and commercial liability and also offered coverage for commercial automobiles and workers' compensation. Its revenues are derived from premiums earned from insurance operations.

About HIND Vyome Holdings Inc.

Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.

Share on Social Networks: